Position in ALXO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,671,200
+$837,501 QoQ
Shares Held
12,884,638
0.0% QoQ
Ownership
9.32%
of shares outstanding
% of Portfolio
5.14%
of 13F equity value
Holder Rank
#2
of 94 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026venBio Partners LLC holds $519,380,252 across 7 Biotechnology names. ALXO ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
|
4,643,430 | $160,569,809 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
5,266,697 | $144,149,496 | |
| 3 | ALMS |
Alumis Inc.
|
4,528,408 | $127,429,401 | |
| 4 | ACHV |
Achieve Life Sciences, Inc.
|
5,914,720 | $38,623,121 | |
| 5 | ALXO |
Alx Oncology Holdings Inc
This page
|
12,884,638 | $26,671,200 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
472,194 | $17,192,583 | |
| 7 | LYEL |
Lyell Immunopharma, Inc.
|
337,697 | $4,744,642 |
All Filings in ALXO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,671,200 | 12,884,638 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,833,699 | 12,884,638 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,960,915 | 9,699,925 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,750,862 | 9,699,925 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,025,468 | 9,699,925 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,043,053 | 9,699,925 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,198,874 | 9,699,925 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,653,863 | 9,699,925 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $58,490,547 | 9,699,925 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $108,154,163 | 9,699,925 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $144,431,883 | 9,699,925 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $46,559,640 | 9,699,925 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $72,846,436 | 9,699,925 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $43,843,661 | 9,699,925 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $109,318,154 | 9,699,925 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $92,828,282 | 9,699,925 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $78,472,393 | 9,699,925 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $163,928,732 | 9,699,925 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $208,451,388 | 9,699,925 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $716,436,460 | 9,699,925 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $530,391,899 | 9,699,925 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $715,272,469 | 9,699,925 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $836,133,535 | 9,699,925 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $366,075,169 | 9,699,925 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||